Echo Street Capital Management’s Twist Bioscience TWST Stock Holding History

Echo Street Capital Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-15,701	Closed	-$553K	–	651
2022 Q3	$553K	Buy	+15,701	New	+$667K	0.01%	249
2022 Q2	–	Sell	-14,861	Closed	-$734K	–	716
2022 Q1	$734K	Buy	14,861 +2,333	+19%	+$129K	0.01%	308
2021 Q4	$970K	Buy	+12,528	New	+$1.29M	0.01%	257
2021 Q3	–	Sell	-6,147	Closed	-$819K	–	757
2021 Q2	$819K	Buy	6,147 +3,998	+186%	+$465K	0.01%	232
2021 Q1	$266K	Buy	+2,149	New	+$326K	﹤0.01%	444

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Echo Street Capital Management's TWST Position: Q4 2022 in Review

Echo Street Capital Management sold out of Twist Bioscience (TWST) in Q4 2022, closing a stake of 15,701 shares — an estimated $553K sold.

Echo Street Capital Management first reported a position in TWST in Q1 2021 and held it in 5 quarters. The position peaked at $970K in Q4 2021. 197 funds tracked by Wall St. Rank hold TWST as of Q4 2022.

Echo Street Capital Management reported no remaining Twist Bioscience position as of Q4 2022 after selling out during the quarter.
Echo Street Capital Management sold 15,701 Twist Bioscience shares in Q4 2022, an estimated $553K.
Echo Street Capital Management first reported a position in Twist Bioscience in Q1 2021 and held it in 5 quarters.
Echo Street Capital Management's Twist Bioscience position peaked at $970K in Q4 2021.
197 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2022.

Based on Echo Street Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.